Denis Dufrane
Chief Executive Officer at Novadip Biosciences SA
Denis Dufrane active positions
| Companies | Position | Start | End |
|---|---|---|---|
Novadip Biosciences SA
 Novadip Biosciences SA BiotechnologyHealth Technology Novadip Biosciences SA operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases. Its proprietary product, Creost, is a natural scaffold-free and tridimensional bone structure, which reconstructs large bone defects without the need of any biomaterial. The firm is a osteogenic living implant with a mineralization similar to a real bone. Its Creost is an autologous cell based-therapy product obtained from Adipose-derived Mesenchymal Stem Cells (AMSCs) which promotes (i) a perfect engraftment without any scaffold and (ii) a tissue remodeling with all native bone properties. Novadip Biosciences was founded by Jean-Fran?ois Pollet and Denis Dufrane in 2013 and is headquartered in Louvain-la-Neuve, Belgium. | Director/Board Member | - | - |
| Chief Executive Officer | 01/01/2013 | - | |
| Chief Tech/Sci/R&D Officer | 01/01/2013 | - | |
| Founder | 01/01/2013 | - | |
| Superior Health Council | Corporate Officer/Principal | - | - |
Career history of Denis Dufrane
Former positions of Denis Dufrane
| Companies | Position | Start | End |
|---|---|---|---|
Cliniques Universitaires Saint-Luc
 Cliniques Universitaires Saint-Luc Hospital/Nursing ManagementHealth Services Cliniques Universitaires Saint-Luc operates as a hospital which provides reference care and treats serious, rare or complex diseases of patients. The company was founded on August 23, 1976 and is headquartered in Brussels, Belgium. | Corporate Officer/Principal | 01/01/2002 | 01/08/2015 |
Statistics
International
| Belgium | 4 |
Operational
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectoral
| Health Technology | 2 |
| Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
Novadip Biosciences SA
Novadip Biosciences SA BiotechnologyHealth Technology Novadip Biosciences SA operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases. Its proprietary product, Creost, is a natural scaffold-free and tridimensional bone structure, which reconstructs large bone defects without the need of any biomaterial. The firm is a osteogenic living implant with a mineralization similar to a real bone. Its Creost is an autologous cell based-therapy product obtained from Adipose-derived Mesenchymal Stem Cells (AMSCs) which promotes (i) a perfect engraftment without any scaffold and (ii) a tissue remodeling with all native bone properties. Novadip Biosciences was founded by Jean-Fran?ois Pollet and Denis Dufrane in 2013 and is headquartered in Louvain-la-Neuve, Belgium. | Health Technology |
Cliniques Universitaires Saint-Luc
Cliniques Universitaires Saint-Luc Hospital/Nursing ManagementHealth Services Cliniques Universitaires Saint-Luc operates as a hospital which provides reference care and treats serious, rare or complex diseases of patients. The company was founded on August 23, 1976 and is headquartered in Brussels, Belgium. | Health Services |
| Superior Health Council |
- Stock Market
- Insiders
- Denis Dufrane
- Experience
